المؤلفون: Jongo S; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Church LWP; Sanaria Inc., Rockville, Maryland, USA., Milando F; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Qassim M; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Schindler T; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Rashid M; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Tumbo A; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Nyaulingo G; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Bakari BM; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Athuman Mbaga T; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Mohamed L; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Kassimu K; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Simon BS; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Mpina M; Ifakara Health Institute (IHI), Bagamoyo, Tanzania.; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Zaidi I; Laboratory of Malaria Immunology and Vaccinology and., Duffy PE; Laboratory of Malaria Immunology and Vaccinology and., Swanson PA 2nd; Vaccine Research Center, NIH, Bethesda, Maryland, USA., Seder R; Vaccine Research Center, NIH, Bethesda, Maryland, USA., Herman JD; Division of Infectious Disease, Brigham and Women's Hospital, Boston, Massachusetts, USA.; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Mendu M; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Zur Y; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Alter G; The Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA., Kc N; Sanaria Inc., Rockville, Maryland, USA.; Protein Potential LLC, Rockville, Maryland, USA., Riyahi P; Sanaria Inc., Rockville, Maryland, USA., Abebe Y; Sanaria Inc., Rockville, Maryland, USA., Murshedkar T; Sanaria Inc., Rockville, Maryland, USA., James ER; Sanaria Inc., Rockville, Maryland, USA., Billingsley PF; Sanaria Inc., Rockville, Maryland, USA., Sim BKL; Sanaria Inc., Rockville, Maryland, USA.; Protein Potential LLC, Rockville, Maryland, USA., Richie TL; Sanaria Inc., Rockville, Maryland, USA., Daubenberger C; Swiss Tropical Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland., Abdulla S; Ifakara Health Institute (IHI), Bagamoyo, Tanzania., Hoffman SL; Sanaria Inc., Rockville, Maryland, USA.

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 Jan 09; Vol. 134 (6). Date of Electronic Publication: 2024 Jan 09.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/complications , Malaria Vaccines*/immunology , Malaria, Falciparum*/prevention & control, Adolescent ; Adult ; Humans ; Middle Aged ; Young Adult ; Antibodies, Protozoan ; East African People ; Plasmodium falciparum ; Tanzania ; HIV Seronegativity ; HIV Seropositivity ; Vaccine Efficacy

المؤلفون: Ali AM; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Gausi K; Division of Clinical Pharmacology, Department of Medicine, University of Cape Towngrid.7836.a, Cape Town, South Africa., Jongo SA; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Kassim KR; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Mkindi C; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Simon B; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Mtoro AT; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Juma OA; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Lweno ON; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Gwandu CH; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Bakari BM; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Mbaga TA; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Milando FA; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Hamad A; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Shekalaghe SA; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Abdulla S; Ifakara Health Institutegrid.414543.3, Bagamoyo, Tanzania., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Towngrid.7836.a, Cape Town, South Africa., Penny MA; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.

المصدر: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2022 May 17; Vol. 66 (5), pp. e0169621. Date of Electronic Publication: 2022 Apr 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-6596 (Electronic) Linking ISSN: 00664804 NLM ISO Abbreviation: Antimicrob Agents Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Antimalarials*/adverse effects , Artemisinins*/adverse effects , Folic Acid Antagonists* , Malaria, Falciparum*/drug therapy , Naphthoquinones*/therapeutic use, 1-Naphthylamine/analogs & derivatives ; Adolescent ; Adult ; Aminoquinolines ; Body Weight ; Child ; Humans ; Tanzania

المؤلفون: Jongo SA; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Church LWP; Sanaria Inc., Rockville, Maryland, USA., Mtoro AT; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Schindler T; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Chakravarty S; Sanaria Inc., Rockville, Maryland, USA., Ruben AJ; Sanaria Inc., Rockville, Maryland, USA., Swanson PA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Kassim KR; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Mpina M; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Tumbo AM; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Milando FA; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Qassim M; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Juma OA; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Bakari BM; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Simon B; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., James ER; Sanaria Inc., Rockville, Maryland, USA., Abebe Y; Sanaria Inc., Rockville, Maryland, USA., Kc N; Sanaria Inc., Rockville, Maryland, USA., Saverino E; Sanaria Inc., Rockville, Maryland, USA., Fink M; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Cosi G; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Gondwe L; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Studer F; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Styers D; The Emmes Corporation, Rockville, Maryland, USA., Seder RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Schindler T; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Billingsley PF; Sanaria Inc., Rockville, Maryland, USA., Daubenberger C; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Sim BKL; Sanaria Inc., Rockville, Maryland, USA.; Protein Potential LLC, Rockville, Maryland, USA., Tanner M; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Switzerland., Richie TL; Sanaria Inc., Rockville, Maryland, USA., Abdulla S; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Hoffman SL; Sanaria Inc., Rockville, Maryland, USA.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Dec 31; Vol. 71 (11), pp. 2849-2857.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Malaria*/prevention & control , Malaria Vaccines* , Malaria, Falciparum*/prevention & control, Adult ; Animals ; Europe ; Humans ; Mali ; Plasmodium falciparum ; Sporozoites ; Tanzania

المؤلفون: Jongo SA; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Church LWP; Sanaria, Inc., Rockville, Maryland., Mtoro AT; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Chakravarty S; Sanaria, Inc., Rockville, Maryland., Ruben AJ; Sanaria, Inc., Rockville, Maryland., Swanson PA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Kassim KR; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Mpina M; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., Tumbo AM; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., Milando FA; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Qassim M; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Juma OA; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Bakari BM; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Simon B; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., James ER; Sanaria, Inc., Rockville, Maryland., Abebe Y; Sanaria, Inc., Rockville, Maryland., Kc N; Sanaria, Inc., Rockville, Maryland., Saverino E; Sanaria, Inc., Rockville, Maryland., Gondwe L; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., Studer F; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., Fink M; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., Cosi G; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., El-Khorazaty J; The Emmes Corporation, Rockville, Maryland., Styers D; The Emmes Corporation, Rockville, Maryland., Seder RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Schindler T; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., Billingsley PF; Sanaria, Inc., Rockville, Maryland., Daubenberger C; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., Sim BKL; Protein Potential LLC, Rockville, Maryland.; Sanaria, Inc., Rockville, Maryland., Tanner M; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute, Basel, Switzerland., Richie TL; Sanaria, Inc., Rockville, Maryland., Abdulla S; Ifakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania., Hoffman SL; Sanaria, Inc., Rockville, Maryland.

المصدر: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2019 Jun; Vol. 100 (6), pp. 1433-1444.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Print Cited Medium: Internet ISSN: 1476-1645 (Electronic) Linking ISSN: 00029637 NLM ISO Abbreviation: Am J Trop Med Hyg Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Protozoan/*blood , Malaria Vaccines/*immunology , Malaria, Falciparum/*prevention & control , Plasmodium falciparum/*immunology , T-Lymphocytes/*physiology, Adolescent ; Adult ; Antibody Formation ; Child ; Child, Preschool ; Double-Blind Method ; Female ; Humans ; Infant ; Malaria Vaccines/adverse effects ; Male ; Middle Aged ; Tanzania ; Vaccines, Attenuated

المؤلفون: Jongo SA; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Shekalaghe SA; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Church LWP; Sanaria Inc., Rockville, Maryland., Ruben AJ; Sanaria Inc., Rockville, Maryland., Schindler T; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland., Zenklusen I; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland., Rutishauser T; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland., Rothen J; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland., Tumbo A; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Mkindi C; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Mpina M; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Mtoro AT; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Ishizuka AS; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Kassim KR; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Milando FA; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Qassim M; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Juma OA; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Mwakasungula S; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Simon B; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., James ER; Sanaria Inc., Rockville, Maryland., Abebe Y; Sanaria Inc., Rockville, Maryland., Kc N; Sanaria Inc., Rockville, Maryland., Chakravarty S; Sanaria Inc., Rockville, Maryland., Saverino E; Sanaria Inc., Rockville, Maryland., Bakari BM; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Billingsley PF; Sanaria Inc., Rockville, Maryland., Seder RA; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Daubenberger C; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland., Sim BKL; Protein Potential LLC, Rockville, Maryland.; Sanaria Inc., Rockville, Maryland., Richie TL; Sanaria Inc., Rockville, Maryland., Tanner M; University of Basel, Basel, Switzerland.; Swiss Tropical and Public Health Institute (Swiss TPH), Basel, Switzerland., Abdulla S; Bagamoyo Research and Training Centre, Ifakara Health Institute, Bagamoyo, Tanzania., Hoffman SL; Sanaria Inc., Rockville, Maryland.

المصدر: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2018 Aug; Vol. 99 (2), pp. 338-349. Date of Electronic Publication: 2018 Jun 21.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: American Society of Tropical Medicine and Hygiene Country of Publication: United States NLM ID: 0370507 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-1645 (Electronic) Linking ISSN: 00029637 NLM ISO Abbreviation: Am J Trop Med Hyg Subsets: MEDLINE

مواضيع طبية MeSH: Immunogenicity, Vaccine*, Malaria Vaccines/*therapeutic use , Malaria, Falciparum/*prevention & control , Plasmodium falciparum/*immunology , Sporozoites/*immunology, Administration, Intravenous ; Adult ; Double-Blind Method ; Human Experimentation ; Humans ; Immunization/adverse effects ; Malaria Vaccines/adverse effects ; Male ; Tanzania ; Young Adult